eClinical Software: September 2009
Applied Clinical Trials
The latest eclinical software in the clinical trials industry.
Patient Enrollment Software Updated
TCN 5.0 expands metrics and risk mitigation for key areas
BBK Worldwide (Newton, MA) announces TrialCentralNet (TCN) 5.0, its patient recruitment management system for sites and sponsors. TCN 5.0 features a robust communications infrastructure, tools for proactive planning of enrollment efforts, targeted site selection criteria, a recruitment development and implementation process, efficiencies for patient enrollment, and instant reporting on randomization and retention metrics.
In addition, TCN 5.0 features improved graphical interfaces for study site personnel and improved function across multiple browser platforms. The new version can be integrated with other clinical data systems as well as other TCN eSystems related to patient recruitment.
BBK Worldwide, (617) 630-4477, www.bbkworldwide.com
Protocol Manager 8.0 Delivers Web Availability
CRAs' needs also addressed in upgraded version of software
Winchester Business Systems (Woburn, MA) announced its Protocol Manager Version 8.0 CTMS, which now features Web-enabled access to authorized users worldwide. Also, a new Clinical Study Portal designed for CRAs joins the already existing portal for investigators.
Winchester CTMS developers have retained the IBM Lotus Domino platform, citing its broad offerings for workflow and application security. In addition, it eliminates the need to obtain separate components to serve as database manager, collaboration manager, email router, security system or Web server.
Winchester customers can purchase or upgrade to Version 8.0 CTMS by Enterprise Adoption, a traditional licensing model, or choose the optional hosting pricing model, featuring Software as a Service and paying on a trial-by-trial basis.
Winchester Business Systems, (781) 203-0200, www.wbsnet.com
Oversight of Global Clinical Trials
Clinical Quality Management Solution addresses process and compliance
Sparta Systems (Holmdel, NJ) announced TrackWise Clinical Quality Management Solution to provide end-to-end streamlining of clinical trial processes and ensure compliance with global regulatory standards. This extension of the TrackWise enterprise quality management system (EQMS) begins with preclinical activities through manufacturing and postmarket operations.
TrackWise Clinical Trial Quality Management Solution provides closed-loop process support to allow issues to be reconciled and corrected before they escalate. The solution manages incidents, structured audit programs specifically tailored around clinical trial execution, the associated CAPA and change control processes, as well as trial registration and trial documentation/SOPs.
Sparta Systems, (888) 261-5948, http://www.spartasystems.com
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
New Data Emerges from Phase IIb RELIEVE UCCD Study in Ulcerative Colitis and Crohn’s Disease
February 25th 2025Following initial positive results shared by Teva and Sanofi in December 2024, new data shows duvakitug (TEV’574/SAR447189) achieved higher rates of clinical remission compared to placebo in the advanced therapy-experienced subgroup.
